The synthesis and applications of chiral pyrrolidine functionalized metal–organic frameworks and covalent-organic frameworks

Mi Zhou a, El-Sayed M. El-Sayed abc, Zhanfeng Ju a, Wenjing Wang a and Daqiang Yuan *a
aState Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, China. E-mail: ydq@fjirsm.ac.cn
bUniversity of the Chinese Academy of Sciences, Beijing, China
cChemical Refining Laboratory, Refining Department, Egyptian Petroleum Research Institute, Nasr City, Egypt

Received 28th August 2019 , Accepted 3rd December 2019

First published on 4th December 2019


Abstract

Proline is a natural amino acid that can be considered as an excellent, efficient, and versatile organocatalyst for various asymmetric reactions. The encapsulation of organocatalysts, such as proline and related derivatives, into a porous material, can not only construct a novel heterogeneous catalyst but also provide a platform to mimic and explore the catalytic processes in a biological system. In this regard, metal–organic frameworks (MOFs) and covalent-organic frameworks (COFs) show superiority because of their crystalline structure, rational designable and tunable framework. In this review, we mainly focus on chiral pyrrolidine functionalized MOFs and COFs; the synthetic strategies and related applications of these materials have been summarized systematically.


1. Introduction

The twenty natural amino acids are essential substances for living systems; meanwhile, nineteen of them exist in nature with an L-configuration. The cheap and naturally available optically pure amino acids also play an indispensable role in chiral pools.1 Among them, proline is distinctive because of its semi-rigid structure. Although proline has a simple structure and relatively small molecular size, the perfect combination of a secondary amine and a carboxylic acid in a semi-rigid molecule makes it an efficient and versatile organocatalyst for a series of asymmetric catalytic processes, including aldol reaction, Mannich reaction, Michael reaction, Diels–Alder reaction, α-amination of aldehydes, and α-alkylation of aldehydes.2,3 And pyrrolidine–NH was proposed to be crucial for the activation of the aldehyde or ketone.

Due to their small molecular size, outstanding performance in asymmetric catalysis and facile functionalization, proline and related derivatives have been incorporated into porous silica4–6 and traditional inorganic porous crystalline materials such as zeolite7,8 to construct heterogeneous catalysts. However, these materials always display limited BET surface area; furthermore, the weak interaction of the host material and the guest functional molecules always leads to undesired guest leaching. Covalently bonded polymer like resin9–12 and porous organic polymers13–18 also have been applied in heterogeneous catalysis, but the amorphous framework, irregular channel and widely distributed pore size inevitably lead to an uncontrollable catalytic environment.

Metal–organic frameworks (MOFs)19 and covalent organic frameworks (COFs)20 attract extensive attention for their potential magnetism,21,22 adsorption,23,24 luminescence,25,26 and electrochemical applications.27–29 Meanwhile, MOFs and COFs are advanced host platforms that can construct novel heterogeneous catalysts due to their long-range ordered structures, highly accessible surface areas, tunable and uniform channel sizes, and rational designable frameworks.30–36 Among porous materials, MOFs and COFs possess advantages like: (a) a designable structure ensuring the feasibility of functionalization; (b) a crystalline framework providing a platform to install the functional fragments in a specific and ordered environment; and (c) diverse sites and various functionalization methods to fulfill efficient immobilization of various types of functional molecules.

From the point of application, the natural chiral and cheap proline with a relatively small molecular size is a perfect chiral source to insert into MOFs and COFs with channels from a few angstroms to a few nanometers. Moreover, the introduction of proline and related derivatives into well-defined frameworks such as MOFs and COFs may result in frameworks which are: (a) elegant materials for sensitive and accurate molecular recognition; (b) chiral heterogeneous catalysts with proline-like catalytic ability; (c) novel platforms to mimic and explore the functionality of the natural enzymes; and (d) hybrid frameworks for complex catalytic processes such as tandem catalysis and synergetic catalysis. It should be mentioned that this review is mainly focused on MOFs and COFs functionalized with proline or proline derivatives, while related research studies based on porous silica, zeolite, resin, and porous organic polymers are not included.

2. Chiral pyrrolidine-functionalized MOFs

In the past few decades, due to their porous, designable, crystalline, and organic–inorganic hybrid structures, MOFs have become an engaging research field. Due to the perfect combination of metal ions and organic linkers, MOFs are perceived as novel platforms to load active sites behaving as heterogeneous catalysts.37–41 Evoked by the report of the pioneering work on homochiral MOFs by Kim et al.,42 synthetic strategies such as chiral induction,43 direct syntheses from privileged ligands,32,36,44 coordinate postsynthetic modification,45,46 covalent postsynthetic modification,47 postsynthetic deprotection,48 and linker exchange49 have been established for desired chiral crystalline porous materials.50

In terms of functional molecular fragments, apart from achiral tectons such as salphen,51 pyenH2,52 and urea,53,54 chiral molecular motifs such as salen,55–57 binol,58–60 binap,61,62 spiro,63 and proline also have been employed to construct MOFs as heterogeneous catalysts. In general, proline shows difficulty in assembling into 3-periodic frameworks due to its convergent molecular structure despite its versatile coordination behavior. The carboxylic group of proline can function as an efficient coordinate site with µ1-O, µ2-O, and even µ3-O coordinate modes. Simultaneously, N and O in each proline molecule are suitable for chelating metal ions synergistically (especially for soft Lewis acid metal ions) and form a stable five-membered ring due to the adjacent alignment of pyrrolidine–NH and the carboxylate group. However, the unoccupied secondary amine is fundamental for the catalytic potency of proline, and the occupied N site will lead to deactivation of proline (Fig. 1a and b).


image file: c9qi01103j-f1.tif
Fig. 1 The common coordinate mode for proline.

To overcome the consequences generated by the convergent structure of proline, it is crucial to modify proline to qualify for the synthesis of MOFs. In the case of ligand design, the typical method to functionalize proline is based on the renovation of pyrrolidine–NH or the carboxylic acid (Scheme 1). Once again, there is no doubt that the functionalization of pyrrolidine–NH will block the catalytic site, while the modification of the carboxylic acid may furnish the pyrrolidine as a pendant fragment. Based on these ligands, except MOFs with a single proline site that have been published, complex systems such as MOFs with a combination of multiple active sites in one single framework for synergetic catalysis and tandem catalysis have also been established (Table 1). In general, these proline-based MOFs can be classified into four groups in terms of catalytic sites: (2.1) MOFs with blocked pyrrolidine–NH sites; (2.2) MOFs with single unoccupied pyrrolidine–NH; (2.3) pyrrolidine-functionalized MOFs with a tunable catalytic environment and (2.4) pyrrolidine-based MOFs with multi-catalytic sites.


image file: c9qi01103j-s1.tif
Scheme 1 The structure of proline and the derived ligands.
Table 1 Heterogeneous catalysis based on chiral pyrrolidine functionalized MOFs
MOF Active group Catalytic reaction Enantioselectivity Ref.
Although both enantiomers of these frameworks have been constructed in most of these references, only one of the enantiomers is displayed in this table for clarity.
L-1 Open Cu(II) site Oxidative coupling 71
DUT-67-Pro Pyrrolidine NH Michael addition 25–38% ee 98
UiO-66-LP Pyrrolidine NH Aldol reaction 99
UiO-67-LP
Zr-NDC-LP
CMIL-1 Pyrrolidine NH Aldol reaction 52–81% ee 102
CMIL-2 Open Cr(III) site
CMIL-101 Amide group Reduction 34–37% ee 103
Open Cr(III) site
Zn-MOF1 Pyrrolidine NH Aldol reaction 48–73% ee 104
Al-MIL-101-NH-Gly-Pro Pyrrolidine NH Aldol reaction 17–27% ee 106
IRMOF-Pro Pyrrolidine NH Aldol reaction 14–29% ee 107
DUT-32-NHPro Pyrrolidine NH Aldol reaction 109
L10/H2N-MIL-101(Al) Pyrrolidine NH Aldol reaction 20–29% ee 110
UiO-67-NHPro Pyrrolidine NH Aldol reaction 111
UiO-68-NHPro
LCuPRO Pyrrolidine NH Baylis–Hillman reaction 112
UHM-25-Pro Pyrrolidine NH Aldol reaction 40% ee 113
MTV-(CH3)0.8(CH2NH–Pro-NH2)0.2 Pyrrolidine NH α-Chlorination of butyraldehyde 20% ee 117
MUF-77 Pyrrolidine NH Aldol reaction 3.3–26.5% ee 124
MUF-77 Pyrrolidine NH Aldol reaction 0.3–27.7% ee 125
Zn-PYI1 Pyrrolidine NH Photocatalytic α-alkylation of aliphatic aldehydes 78–92% ee 128
Triphenylamine
INP-1 Pyrrolidine NH Photocatalytic β-arylation of saturated aldehydes 28–55% ee 129
Triphenylamine
Ni-PYI1 Pyrrolidine NH Tandem catalysis for epoxidation and hydrolysis 67–95% ee 131
[BW12O40]5−
ZnW-PYI1 Pyrrolidine NH Tandem catalysis for epoxidation and cycloaddition 55–96% ee 132
[ZnW12O40]6−
Open Zn(II) site
CuW-PYI1 Pyrrolidine NH Tandem catalysis for aldol reaction and epoxidation 70.6–86.2% ee 133
[PW12O40]3−
CZJ-18(Cu)-Pro Pyrrolidine NH Aldol reaction 29–88% ee 138
Porphyrin–Cu(II)
L16@3 Pyrrolidine NH Aldol reaction 66–80% ee 140
Carboxylic acid
MIL-101-PP1 Pyrrolidine NH Aldol reaction 87–96% ee 146
Open Cr(III) site


2.1. MOFs with blocked pyrrolidine–NH sites

At the early stage of proline-based MOFs, commercially available proline was employed as a ligand to construct chiral frameworks directly. And it is common to produce a convergent structure or a 1D-chain structure with proline, rare studies on 2D or 3D extended structures have been reported.

In 2006, Su et al. employed proline as an organic chiral source for construction of a pair of chiral framework enantiomers with a high-charge Keggin-type polyoxometalate (POM). Proline binds to Cu(II) forming a 1D coordinated chain primarily, and then the chains were further imparted by [BW12O40]5− with Cu–O bonds to construct the 3-periodic framework. It should be mentioned that all the coordinate sites of proline take part in the self-assembly; so no accessible pyrrolidine–NH site exists in this framework.64 This work reported the first pairs of proline-based homochiral open 3-periodic frameworks, and from then on reports about proline based frameworks started to spring up. In 2007, Rosseinsky et al. packed proline, 4,4′-bipyridyl (BPY), and Zn(II) or Cd(II) into two 2D coordination polymers. The 1D cationic chain constructed from proline and the metal ion was linked with BPY in the 2D plane; meanwhile, active pyrrolidine–NH was occupied by intra-layer hydrogen bonds and balanced anions.65

For building an extended 3-periodic chiral framework with proline efficiently, some multi-topic ligands by functionalizing pyrrolidine–NH have been designed and synthesized (Scheme 1). These ligands can aptly deliver chirality to MOFs but without proline-like catalytic activity. In 2006, Xiong et al. built a 3-periodic MOF based on the in situ synthesis of flexible L1. Due to the flexible nature of L1, the chiral L1 based network crystallizes in a noncentrosymmetric space group without accessible pores; the crystal can be a potential candidate for second-order nonlinear materials and ferroelectric materials.66

In general, the presence of accessible pores and channels is crucial for applications such as adsorption,67,68 molecular recognition,69 and organic catalysis. Inspired by the excellent work of HKUST-170 on 1,3,5-benzenetricarboxylic acid (BTC) with a relatively small size, Zhang et al. designed the functional ligand L2 by replacing one of the carboxylic groups of BTC with proline. After being self-assembled with Cu(II), two pairs of enantiomeric homochiral MOFs (L-1/D-1 and L-2/D-2) were constructed with proline decorated cages, and the structural difference of L-1 and L-2 is derived from the variability of the solvent system. L-1 not only exhibits higher porosity (43% vs. 38%) and BET area (250.7 vs. 165.3 m2 g−1) than L-2 but also contains extra open Cu(II) sites. Due to the existence of accessible Lewis acid sites, L-1 exhibits catalytic activity for the synthesis of β-lactam while L-2 is sluggish in the catalysis (Fig. 2).71


image file: c9qi01103j-f2.tif
Fig. 2 Schematic presentation of the construction of compound L-1 and the catalytic synthesis of β-lactam.

Constructing size-matching MOFs for chiral recognition is particularly attractive yet challenging.72,73 The reaction of L2 and Cd(II) resulted in one pair enantiomeric MOFs with four kinds of helical chains existing in the structure, and the absolute helicity of these chains is attributed to the chirality of the ligand. The obtained MOF shows size-dependent enantioselective adsorption behavior as it can adsorb methyl lactate with higher enantioselectivity than ethyl lactate (68.3% vs. 14.9% ee value), although only a slight difference exists between the two substances.74 Furthermore, they adopted a mixed-ligand strategy from semi-rigid L2 and rigid 1,3,5-tri(1H-imidazol-1-yl)benzene (TIB) to react with Cd(II) for more porous MOFs. The afforded framework possesses two kinds of cage units and an srs topology with 49.2% porosity and 955.8 m2 g−1 BET surface area. Moreover, the chiral framework displays moderate enantioselective adsorption for methyl lactate (34.8% ee).75

In 2017, via extending the design strategy to 1,4-benzenedicarboxylic acid (BDC) and biphenyl-4,4′-dicarboxylic acid (BPDC), Wu et al. synthesized two flexible ligands L3 and L4 functionalized with two proline groups. The integration of bipyridyl ligands, metal ions, and L3 or L4 generated two pairs of ladderlike metal–organic layers with a nanoscale channel. Enantioselective adsorption experiments demonstrated that the metal–organic layer with a larger channel shows better enantioselectivity for a bulkier substrate—the ee value for the adsorbed substrate increases from 12.03% for 1-phenyl-1,2-ethanediol to 56.86% for hydrobenzoin and 67.44% for 1,1,2-triphenyl-1,2-ethane-diol.76

2.2. MOFs with single unoccupied pyrrolidine–NH

Due to the blockage of the pyrrolidine–NH group, the pyrrolidine fragment in the above-mentioned frameworks only functions as a linker to supply a chiral environment but without the catalytic capacity of proline. According to the proposed mechanism of proline catalysis, it is critical to maintain the pyrrolidine–NH group unoccupied to construct a framework with proline-like catalytic activity.

As is well-known, monocarboxylic acids are powerful regulators for highly crystallized MOFs with high-connected SBUs from rare-earth metals,77 Ti(IV),78–80 Hf(IV)81,82 and Zr(IV).83,84 As one kind of chiral monocarboxylic acid with an NH group in the ortho-position, proline not only provides versatile coordination modes for the efficient modulation of various SBUs,85 but can also deliver chirality to MOFs from achiral components by chiral induction.86–88 Based on the hard–soft-acid–base theory, it is reasonable to introduce proline into MOFs as a pendant ligand with a hard Lewis-acid metal. The carboxyl group of proline is expected to take part in the coordination while leaving pyrrolidine–NH unoccupied to construct a proline-based heterogeneous catalyst by defect engineering.89–93

The Zr6O4(OH)4(CO2)n cluster is a famous SBU in constructing UIO-type MOFs, and it often acts as a 6-, 8- and 12-connected node.94 Interestingly, the terminal coordinated HCO2 or CH3CO2 for an 8-connected SBU can be replaced by other carboxylic ligands.95–97 Employing the solvent-assisted linker incorporation strategy, Kaskel and Senkovska et al. introduced proline into 8-connected zirconium-based DUT-67 (Fig. 3). The terminal carboxyl groups in DUT-67 were replaced by proline completely with ligand exchange, which can be verified by 1H NMR of the digested sample (2,5-thiophenedicarboxylic acid/proline ≈2[thin space (1/6-em)]:[thin space (1/6-em)]1). Proline functionalized DUT-67-Pro shows activity to catalyze the asymmetric Michael reaction with a moderate ee value (38%). Besides, recycling and leaching experiments demonstrate that proline is firmly bonded to the framework with unoccupied pyrrolidine–NH.98 To simplify the synthetic procedure, Van Der Voort et al. adopted a one-pot method to attach proline in UIO-66, UIO-67 and Zr-NDC with proline as an SBU modulator. Proline can be inserted into the defect of the zirconium cluster successfully. It was found that the decreased synthesis temperature resulted in higher ratio defects, while the stability of the framework decreased consequently. The resulting MOFs can not only catalyze the aldol reaction but also show interesting reversed diastereoselectivity to the homogeneous counterpart.99


image file: c9qi01103j-f3.tif
Fig. 3 Schematic presentation of defect engineered DUT-67 with L-proline.

As the carboxyl group is an efficient group for molecular decoration, ligands based on modifying the carboxyl group of proline have also been established. Zhang et al. designed L5via substituting the carboxylic acid of proline with a tetrazole group. The combination of L5 and Zn(II) or Cd(II) afforded isostructural 2D chiral coordination polymers with pyrrolidine–NH taking part in the formation of a five-membered coordinate ring.100 As pyrrolidine–NH is adjacent to the chelating carboxyl group, to alleviate the tendency of forming a coordinate ring, it is required to modify proline for an elongated ligand. Furthermore, this strategy may result in frameworks with the pyrrolidine protruding into the channel, which may alleviate the excessive hindrance of the channel and benefit the catalysis.

Amidation is a useful method to functionalize the carboxyl group, and several reports about monotopic pyrrolidine based ligands decorated with a pyridyl group have been published. MIL-101 has been extensively explored in the materials field for its robustness, high porosity and hierarchical porous structure, in which the labile terminal H2O on the trichromium SBU can be substituted by an N-donor ligand.101 Kim et al. reported the first case to construct chiral MIL-101 via coordinate postsynthetic modification (Fig. 4). Primarily, they designed and synthesized pyrrolidine functionalized L6 with a 3-pyridyl group and L7 with a 4-pyridyl group, and then L6 and L7 were attached to the SBUs of MIL-101 with a coordination bond to construct two MIL-101 based chiral frameworks. Both chiral frameworks exhibit better catalytic behavior than the corresponding homogeneous ligand toward asymmetric aldol reaction, and the superior enantioselectivity might have been derived from the multiple chiral inductions in the confined space of the heterogeneous catalyst. Interestingly, CMIL-101 functionalized with different ligands affords products with different ee values (76% for L6vs. 58% for L7) although the two ligands only show different positions of the pyridyl group. This indicates that even a minor change of the catalyst may result in much different catalytic behavior. Moreover, the size-dependent experiment demonstrates the intrinsic pore catalysis, while the recycled experiment verifies that the strategy is powerful to load the homogeneous catalyst.102


image file: c9qi01103j-f4.tif
Fig. 4 Schematic depiction of coordinate postsynthetic modification of MIL-101 with proline-derived auxiliary ligands for heterogeneous catalysts.

Followed Kim's work, Zhang et al. found that both MIL-101 and the N-formyl pendant ligand L8 are efficient catalysts for the reduction of ketimines. The integration of chiral L8 and MIL-101 into a chiral heterogeneous catalyst was achieved through coordinate postsynthesis. The resulting material displays remarkable activity as a heterogeneous catalyst for the asymmetric reduction of ketimines (as high as 81% yield and 37% ee).103

Covalent postsynthetic modification is somewhat distinct from the strategy mentioned above via coordination bonds, and this method enables decoration on the organic linker of MOFs with stronger covalent bonds, which reminds us of the functional graft polymer. In 2012, Duan et al. synthesized two achiral MOFs with an ethynyl-decorated channel, and then the chiral 2-azidomethylpyrrolidine (L9) was anchored on the channel quantitatively via click reaction to construct the chiral framework. The resulting pyrrolidine functionalized hybrid material offers good catalytic activity and enantioselectivity toward the aldol reaction (as high as 76% yield and 73% ee).104 With a different postsynthetic reaction, Canivet et al. adopted a solid-state peptide synthetic method to functionalize MOFs. In 2011, they modified In-MIL-68-NH2via creating peptide bonds in the framework. N-Fmoc proline was bound to the amine in the presence of a coupling agent and a weak base additive at room temperature. Relatively low yield was observed which may be related to the bulky Fmoc group and relatively small channel of MIL-68-NH2, though the protecting group can be removed quantitatively at room temperature in the system of piperidine/DMF.105 To circumvent the low yield generated by the bulky Fmoc group, N-Boc amino acid was used for the modification of three amino-functionalized MOFs (Zr-UiO-66-NH2, In-MIL-68-NH2, and Al-MIL-101-NH2) with different porosity, topology, window size and pore size. Upon substituting the conventional heating with microwave irradiation, the reaction time can be shortened from 96 hours to 20 minutes dramatically, and Al-MIL-101-NH2 can be modified with higher yield as a result of a bigger window and cavity in the framework. Furthermore, these pyrrolidine functionalized frameworks can catalyze the aldol reaction smoothly with a moderate ee value.106

Unlike postsynthetic modification that always has disadvantages such as pore blockage and decreased surface area and pore volume, the rational design and synthesis of targeted MOFs from a functional ligand are always fascinating as they endow MOFs with an explicit structure and uniformly distributed high-density functional sites. In 2011, Telfer et al. introduced the proline group into IRMOF-NHPro by designing a linear linker L11 based on BPDC, and N-Boc protected L11 was used to synthesize IRMOF-NHPro-Boc successfully. However, using only naked L11 leads to unsuccessful attempts as a consequence of the interference of unoccupied pyrrolidine–NH in the self-assembly process. The introduction of the bulky Boc group not only ensures the successful synthesis of the targeted MOF but also restricts the framework interpenetration. Moreover, the Boc group will be decomposed into gaseous fragments after thermal treatment at 165 °C for 4 h (Fig. 5), which will retain the unoccupied active sites in the framework. The resulting IRMOF-NHPro presents valuable activity and moderate enantioselectivity toward the aldol reaction (29% ee value).107 This work evoked researchers to explore homochiral MOFs with rationally designed pyrrolidine functionalized linkers.


image file: c9qi01103j-f5.tif
Fig. 5 The structure of IRMOF-Pro based on L11.

The functionality of MOFs with a hierarchical porous structure can be finely tuned with an elaborate choice of an organic linker and SBU, and the independent compartments with different environments in the single framework may be beneficial for diffusion and catalysis.108 For this purpose, Kaskel et al. introduced L11 into DUT-32. Obviously, thermal deprotection is inevitable for the full deprotection of N-Boc. Systematic research about the effect of thermal deprotection condition for DUT-32-NHProBoc on the ee value of the ligand was carried out; unfortunately, the results demonstrate that elevated temperature may lead to undesired racemization. With the temperature increasing to 140 °C, the ee value of the ligand decreased dramatically (Fig. 6), and this is unfavorable for the application of the material in asymmetric catalysis.109


image file: c9qi01103j-f6.tif
Fig. 6 Ee-value evolution of L11 after heating in DMF at 100, 120, and 140 °C.

Compared to thermal treatment, acidic condition is a more effective method to deprotect the Boc group. The chirality of the organic ligands may be maintained in the presence of an acid under milder conditions. With this method, Janiak et al. introduced pyrrolidine functionalized L10 into MIL-101(Al) via a mixed-ligand strategy, and the Boc group was deprotected simultaneously in the self-assembly process. In this way, the in situ deprotection of the Boc group without sacrificing the ee value of the ligand was attained. Although the framework affords products with a lower ee value (29% ee) compared to L-proline (66% ee), it is comparable to the homogeneous dimethyl ester of L10 (21% ee). More importantly, the framework provides the product with reversed enantioselectivity (the framework affords an S-configuration product, while the homogeneous counterpart produces an R-configuration product), which can be attributed to the confinement effect of the framework.110 In 2016, Kaskel et al. introduced L11 and L12 into isoreticular MOFs with different pore and channel sizes to investigate the influence of the cavity size on the catalysis (Fig. 7). They adopted a one-pot strategy to synthesize UIO-67-NHPro with L11 and UIO-68-NHPro with L12, and the Boc group was removed spontaneously in an acidic synthetic system. The following heterogeneous catalysis illustrates that UIO-68-NHPro implies better performance than UIO-67-NHPro in catalyzing the aldol reaction due to the increased pore size and faster substrate diffusion rate (90% vs. 39% yield). Besides, these MOFs also feature unusual opposite diastereoselectivity compared with their homogeneous counterparts, which can be ascribed to the confinement effect of the catalytic site on the catalytic transition state.111 In this manner, the innate configuration preference can be overridden through changing the energy barrier of the transition state when employing a particular MOF as a catalyst.99,111


image file: c9qi01103j-f7.tif
Fig. 7 Structures and cage units of UiO-67-NHPro (top) and UiO-68-NHPro (bottom).

In 2016, Bharadwaj and co-workers synthesized L13 by replacing the benzoic acid of L12 with an isophthalic acid moiety to construct a Cu2(CO2)4 based MOF. Rather than utilizing the N-Boc protected ligand, a highly porous Cu2(CO2)4 based homochiral framework denoted as LCuPRO (63.1% porosity) with two kinds of cage units can be fabricated from unprotected L13 directly. The Lewis-basic proline groups all point to the center of cage A to form a catalytic pocket (Fig. 8a); meanwhile, the substrate and product can diffuse in the framework via cage B freely (Fig. 8b). Experiments revealed that this MOF is a considerable catalyst for the Baylis–Hillman reaction (as high as 75% yield).112 Fröba et al. introduced a series of chiral amino acids into a semi-rigid diisophthalic ligand to decorate the α,α-diaryl amino alcohol-based tetracarboxylic ligand L14 (Fig. 9). A series of isostructural MOFs denoted as UHM-25 crystallized in a cubic space group with a rare ucp topology can be obtained either with N-Boc protected or unprotected ligands. Surprisingly, a much lower BET value can be observed for the nonprotected MOFs than for the N-Boc protected MOFs (371.5 m2 g−1vs. 1922 m2 g−1 for UHM-25-Val to UHM-25-Val-Boc), and it is possibly due to the blockage of solvent molecules bonded with the naked amine group or partial collapse of the framework upon activation. UHM-25-Pro also can catalyze the aldol reaction with a moderate ee value (40%).113 Based on the above results, it should be concluded that the N-Boc protecting group is not necessary for the synthesis of MOFs with a Cu2(CO2)4 SBU but is crucial for the construction of MOFs with a Zn4O(CO2)6 SBU.


image file: c9qi01103j-f8.tif
Fig. 8 Schematic presentation of (a) cage A and (b) cage B in LCuPRO; the pyrrolidine groups are highlighted in bright green and hydrogen atoms are omitted for clarity.

image file: c9qi01103j-f9.tif
Fig. 9 Overview of the different types of linkers used in the UHM-25 MOFs.

2.3. Pyrrolidine-functionalized MOFs with a tunable catalytic environment

The complexity of an enzyme reflects that beside the active site, the surrounding environment is also crucial for the elegant molecular recognition and excellent catalytic efficiency. MOFs with the same backbone but different channel environments no doubt can provide an ideal platform to examine the effects of the surrounding environment on the catalytic activity.

IRMOF-74 is a class of robust and highly porous MOFs with good functional-group tolerance and may be competent in constructing a complex environment with multi-step postsynthetic modifications.114 The derived IRMOF-74-III with an elongated ligand containing an augmented mesoporous hexagonal channel (about 25 Å) has been proven to be a perfect candidate for post-functionalization.115,116 In 2016, Yaghi et al. successfully realized the sequential installation of tripeptides in IRMOF-74-III via seven steps of tandem reactions with an overall yield of 57% and an average yield of 93% for each step (Fig. 10); meanwhile, the crystallinity and permanent porosity of the framework can be maintained after multiple microwave-assisted deprotection and amino acid coupling reactions, which demonstrates that this framework is tolerant to these operations. Moreover, it was detected that aliphatic amine (CH2NHBoc) functionalized IRMOF-74-III exhibits higher reactivity than the framework decorated with an aromatic amine under the identical conditions (∼97% vs. ∼0% yield for anchoring Ala). A further test shows that proline decorated IRMOF-74-III acts as an active catalyst for the α-chlorination of butyraldehyde and affords higher enantioselectivity than its homogeneous counterpart (20% vs. 2% ee).117 This work not only provides an efficient route to construct a complex environment in the mesoporous MOF but also entitles MOFs to act as a container to synthesize complex compounds with multi-step reactions; furthermore, the channel environment can be finely designed and modified via choosing and combining the substrate appropriately.


image file: c9qi01103j-f10.tif
Fig. 10 Seven post-synthetic reactions to achieve enzyme-like complexity in the pores of MTV-IRMOF-74-III-(CH3)0.6(CH2NHBoc)0.4.

Rather than the randomly distributed variable components in post-synthesized MOFs and MTV-MOFs,118 each variant in multicomponent MOFs such as MOF-205, MOF-210,119 UMCM-1–5,120,121 PCN-700–703,95 LIFM-28,122 and MUF-7x123 is orderly distributed in the frameworks. So the catalytic environment of multicomponent MOFs can be finely regulated via elaborately changing the modulator ligands. In 2017, Telfer et al. engineered proline functionalized L10 and L11 into multicomponent MUF-77 with three types of ligands located at specific sites, and the spatial environment of the catalytic pocket can be programmed precisely by tuning the side arm of the other two linkers for the unique structure of MUF-77 consequently; in this manner, the catalytic activity can be modulated efficiently (Fig. 11). As expected, asymmetric aldol reaction indicates that the observed rate constant and enantioselectivity are related to the modulator ligand, with the increasing of the steric-hindrance from the side arms, the rate constant decreases significantly; furthermore, even the configuration of the preferred enantiomer can be reversed with the careful control of the spatial environment.124,125


image file: c9qi01103j-f11.tif
Fig. 11 Schematic depiction of a pore in MUF-77 equipped with a site for catalysis and modulator groups that are positioned to modulate the environment of the reaction.

2.4. Pyrrolidine-functionalized MOFs with multi-catalytic sites

The hybrid and crystalline nature of MOFs provides an opportunity to distribute two or more catalytic sites in one single framework uniformly, and the resulting adduct may act as a unique catalyst for synergetic catalysis and tandem catalysis.126,127 Upon encapsulation of chiral pendant ligand L15 and photoactive 4,4′,4″-tricarboxyltriphenylamine (TCA) in one framework, Duan et al. reported a MOF with excellent asymmetric photocatalytic activity (Fig. 12). The α-alkylation of aliphatic aldehydes can be catalyzed by the hybrid framework smoothly (85% yield) with excellent enantioselectivity (92% ee). However, only negligible amounts of products can be harvested when the experiments are carried out in the dark or with a bulkier aldehyde, which indicates the photocatalytic and heterogeneous nature of this reaction. The physical mixture of an achiral TCA-based MOF and L15 only leads to a moderate ee value (<24%), which expresses the superiority of the strategy in combining a photocatalyst and an asymmetric catalyst in one framework for synergetic catalysis. They proposed that the photoinduced electron can be reduced by the excited TCA ligand to form a radical anion, and then the Br–C bond in diethyl 2-bromomalonate was cleaved by the radical anion to afford an electrophilic radical and a bromide anion; finally, the electrophilic radical combines with the proline activated enamine to furnish the photocatalytic product.128 Following this work, they harvested another 2-fold interpenetrated photocatalytic chiral MOF with a mono-zinc node, TCA and L15 by modifying the synthetic conditions. Further tests explicate that not only the photocatalytic β-arylation of saturated ketones can be realized by the MOF smoothly (87% yield) with a moderate ee value (55%), but also the encapsulation and activation of the aldehyde by hydrogen bonds with the pyrrolidine can be captured and demonstrated by single-crystal XRD and spectral measurements systematically. This case not only shows that a novel catalyst can be constructed with MOFs, but also indicates that MOFs can provide more information about the activation process and the transition state.129
image file: c9qi01103j-f12.tif
Fig. 12 Schematic presentation of integrating photocatalytic TCA and L15 in one framework for α-alkylation of aliphatic aldehydes.

Polyoxometalate is a class of interesting chemicals with prominent redox activity.130 Following a similar strategy, a chiral polyoxometalate-based Ni-PYI was synthesized with the integration of 4,4′-bipyridine, oxidative [BW12O40]5−, chiral ligand L15 and Ni(II), and the Boc group can be removed simultaneously under the acidic conditions. In this way, the encapsulation of the polyoxometalate and pyrrolidine ligand into a 3-periodic chiral oxidative framework was realized. The amphipathic framework proves to be an excellent container and catalyst for asymmetric one-pot tandem catalysis reaction of epoxidation and hydrolysis (Fig. 13). The framework yields dihydroxylated products from a mixture of a hydrophobic aryl olefin and a hydrophilic aqueous oxidant with 79% yield and an ee value as high as 95%. Meanwhile, the hydrolysis of the racemic 2-phenyloxirane only affords racemic products, indicating that the epoxidation reaction of the aryl olefin is the enantioselectivity-determining step. A size-dependent experiment and filtration experiment confirm the heterogeneous and pore-catalysis nature of the reaction.131 Then, NH2–bipyridine, [ZnW12O40]6−, L15 and Zn(II) were assembled into another chiral framework with an open Zn(II) site, a Brønsted basic site, and a redox-active polyoxometalate. The initial test shows that the framework can catalyze the epoxidation of the aryl olefin enantioselectively (94% yield and 93% ee). As the open Zn(II) site is an efficient catalyst for CO2 cyclic addition, the in situ formed epoxy compounds can be converted into high-value chiral cyclic carbonates with as high as 99% yield and 96% ee in the presence of CO2, ZnW-PYI and a cocatalyst. In contrast, a product with only a trace ee value was harvested when a racemic styrene oxide was employed as the starting material, which once again emphasizes that the enantioselectivity comes from the epoxidation rather than from the CO2 cycloaddition reaction.132 Furthermore, Li and Han et al. assembled oxidative PW12O403−, chiral L15 and Lewis acid Cu(II) into a chiral polyoxometalate framework with a Kagomé structure. It was ascertained that the framework could catalyze the asymmetric cascade reaction of the aldol and epoxidation reaction. The dehydrated substance of the aldol reaction followed by epoxidation supplied the product with as high as 72.5% yield and 86.2% ee value.133


image file: c9qi01103j-f13.tif
Fig. 13 Schematic presentation of ZnW-PYI consisting of POM and L15 for tandem catalysis.

Metalloporphyrin is another kind of star molecule, and the metalloporphyrinic MOFs exhibit impressive catalytic performance in oxidation134–136 and CO2 fixation.137 In 2019, Wu et al. constructed a 3-periodic MOF with the reaction of a metalloporphyrinic ligand and Y(III). Interestingly, the Y3 SBU binds to eight carboxylates with another terminal acetate as a balanced anion due to the bulky size and steric hindrance of the metalloporphyrinic ligand. Additionally, the balanced terminal acetate can be substituted by monocarboxylic ligands such as proline and 4-sulfobenzoate; so the pendant ligand and the central metal of porphyrin can be tuned systematically. With the systematic modification of the structure, the resulting framework proves to be a versatile catalyst for the epoxidation of olefins, aerobic oxidation of alcohols, and aldol reaction. The proline functionalized framework can catalyze asymmetric aldol reaction with excellent activity and ee values, and this MOF shows higher diastereoselectivity than the homogeneous L-proline.138

Apart from the organic linker and inorganic node of MOFs, the cavity of MOFs can also be exploited to incorporate functional guests. From the proposed catalytic mechanism of proline based aldol reaction, a Brønsted acid is also critical for high efficiency.139 For realizing the priority of the adduct toward the homogeneous competitor, a reliable strategy is to impart those functional fragments in one framework. In 2014, Cui et al. synthesized a homochiral MOF with free carboxylic acids aligned along the nano-sized channel, and the (S)-2-(dimethylaminomethyl)-pyrrolidine (L16) was then accommodated in the channel via acid–base interactions (Fig. 14). The adduct presents comparable activity and superior enantioselectivity than its homogeneous counterpart in catalyzing aldol reactions, which might have been derived from the synergistic effect of the free carboxylic acid and the introduced pyrrolidine derivative in the confined chiral space.140


image file: c9qi01103j-f14.tif
Fig. 14 Schematic depiction of encapsulating L16 in the MOF with the free carboxylic acid; the frame presents the host MOF.

Linear organic polymers are a class of useful functional materials; however, this kind of material always possesses a relatively low BET and an irregular channel. The hybridization of functional polymers and MOFs in situ not only can increase the accessible polymer surface for the substrate but also endow MOFs with unique functionality.141–145 Liu and Dong et al. realized the in situ mixed polymerizations of vinyl derivatives (L17) to heterogenize a pyrrolidine-functionalized linear polymer into the pore of MIL-101 for heterogeneous chiral catalysis. The crystallinity of MIL-101 was maintained although the hybrid material showed a decreased BET surface area due to the inclusion of the polymer. Furthermore, the hybrid material proved to be an excellent heterogeneous catalyst for asymmetric aldol reaction due to the coexistence of a chiral pyrrolidine fragment and an unoccupied Cr(III) Lewis acid site (as high as 89% yield and 96% ee value).146

3. Pyrrolidine-functionalized COFs

COFs are a class of porous covalently bonded crystalline frameworks, and compared to the coordinate bonds of MOFs, the stronger linkage endows the framework with higher stability toward harsher conditions in the catalytic process. Although chiral catalytic fragments such as salen,147–150 binol,151 tartaric acid derivatives,152–154S-(+)-2-methylpiperazine155 and pyrrolidine156–160 have been inserted into COFs, chiral COFs are still relatively rare.161 In general, the pyrrolidine moiety is incorporated into the COFs via covalent postsynthetic modification or direct synthesis with an N-Boc protecting group to avoid the undesired side reaction.

3.1. Covalent postsynthetic modification

Jiang et al. reported the first chiral COF via postsynthetic modification in 2014. Firstly, they synthesized an achiral COF with alkynyl groups decorated along the square channel. Then, a click reaction was carried out with L9 to install the chiral pyrrolidine on the wall of the COF with the crystallinity of the framework being maintained (Fig. 15). Catalytic experiments illustrate that this pyrrolidine functionalized chiral COF can catalyze the Michael reaction with good yield and moderate enantioselectivity in a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 mixed solution of H2O/EtOH. Besides, the reaction rate is correlated with the ratio of the postsynthesized pyrrolidine. Maybe as a result of the blocked channel and delayed diffusion rate of the substrate, the reaction rate tends to decrease with an increased pyrrolidine loading ratio.156 Furthermore, another mesoporous chiral COF with honeycomb pores was constructed using a similar strategy, and the obtained material shows outstanding catalytic activity with excellent diastereoselectivity and enantioselectivity in the H2O system.157 These pioneering studies reported the novel strategy to construct chiral COFs, and prominent asymmetric catalysis in a green solvent was realized based on these COFs.
image file: c9qi01103j-f15.tif
Fig. 15 Schematic presentation of the postsynthetic strategy to construct a proline based chiral COF.

3.2. Direct synthesis

For avoiding the harmful effects of postsynthetic modification such as reduced accessible surface area, cavity blockage, and randomly distributed catalytic sites, it is reasonable to design and construct chiral COFs from chiral monomers via direct synthesis. In this way, N-Boc protected pyrrolidine has been installed on rigid ditopic and tritopic monomers as a side arm (Scheme 2).
image file: c9qi01103j-s2.tif
Scheme 2 Structure of a proline functionalized monomer for COFs.

In 2016, Wang et al. designed and synthesized a chiral diamine ligand L18 by attaching a pyrrolidine moiety to an achiral linear monomer. Two chiral COFs denoted as LZU-72 and LZU-76 were constructed from the chiral monomer with 1,3,5-triformylbenzene or triformylphloroglucinol, respectively (Fig. 16). Due to the assistance of intramolecular hydrogen bonds,162 LZU-76 shows higher stability than LZU-72. Meanwhile, LZU-76 exhibits excellent activity and enantioselectivity for aldol reactions (as high as 84% yield and 88% ee).158


image file: c9qi01103j-f16.tif
Fig. 16 Schematic presentation of the synthesis of LZU-72 and LZU-76.

In 2017, Cui et al. anchored a series of chiral unit–like pyrrolidine (L19) compounds and a Macmillan catalyst to triamine monomers. 2D MTV-COFs were constructed from these monomers with linear dimethoxyterephthalaldehyde as the chiral moiety protruding into the hexagonal channel. The COFs with different chiral molecular fragments exhibit excellent activities to catalyze a batch of asymmetric reactions such as α-aminooxylation of aldehydes, aldol reaction, and Diels–Alder reaction.159 Recently, they extended this strategy for the synthesis of chiral trialdehyde monomers (L20), and 2D chiral COFs with a chiral moiety were harvested consequently when these monomers reacted with the triamine monomer. The pyrrolidine functionalized COFs are perceived as outstanding catalysts for the asymmetric Michael addition and Steglich rearrangement reaction.160

4. Summary and outlook

Until now, proline and related derivatives have been employed to synthesize chiral MOFs directly; furthermore, the strategies such as ligand design and postsynthetic modification have also been adopted to construct chiral MOFs and COFs with active unoccupied pyrrolidine–NH. Asymmetric catalytic processes, including characteristic proline catalysis, synergetic catalysis, and tandem catalysis, with the obtained frameworks as heterogeneous catalysts have also been established.

It can be envisioned that except the recyclability for the heterogeneous catalysts, porous crystalline frameworks may participate in some unique applications. Firstly, these frameworks can be employed to conduct substrate or product size-selective catalysis. Despite catalytic site like pyrrolidine in the crystalline framework maybe not as active as the homogeneous counterpart for hampered diffusion rates and the tendency of coordination saturation163 for active sites in the self-assembly process. However, the confinement effect of MOFs and COFs derived from the windows, pores, and walls of the framework may mitigate the side reaction and even override the innate molecular preference through changing the energy barrier of the transition state for specific molecules. Secondly, the porous frameworks can be utilized to explore the generic activation mode of the catalytic mechanism and determine the active transition-state species with MOFs. Due to the crystalline character, especially the single-crystal nature of most MOFs, the extra lattice energy and steric hindrance make it possible to develop active MOFs as crystalline sponge164,165 to stabilize the transition-state species, and this can be measured by single-crystal X-ray diffraction directly. Finally, the scope of heterogeneous catalytic reactions with crystalline frameworks as catalysts may be extended with COFs. Due to the relatively fragile nature of the coordination bonds in MOFs, most of them are unstable to acids, bases, and even moisture. For the COFs with a stronger linkage, it may provide an opportunity to conduct the heterogeneous reaction under harsher conditions such as in aqueous, acidic, and basic media. This undoubtedly will broaden the range of the catalytic reaction with COFs as heterogeneous catalysts.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB20000000), the Key Research Program of Frontier Sciences, Chinese Academy of Sciences (QYZDB-SSW-SLH019), and the National Natural Science Foundation of China (21905281 and 21771177).

Notes and references

  1. H. U. Blaser, Chem. Rev., 1992, 92, 935–952 CrossRef CAS.
  2. D. W. MacMillan, Nature, 2008, 455, 304–308 CrossRef CAS.
  3. B. List, Acc. Chem. Res., 2004, 37, 548–557 CrossRef CAS PubMed.
  4. C. Yu and J. He, Chem. Commun., 2012, 48, 4933–4940 RSC.
  5. P. Van der Voort, D. Esquivel, E. De Canck, F. Goethals, I. Van Driessche and F. J. Romero-Salguero, Chem. Soc. Rev., 2013, 42, 3913–3955 RSC.
  6. S. Lacasta, V. C. Sebastián, C. Casado, A. L. Mayoral, P. Romero, A. N. Larrea, E. Vispe, P. López-Ram-de-Viu, S. Uriel and J. N. Coronas, Chem. Mater., 2011, 23, 1280–1287 CrossRef CAS.
  7. B. M. Weckhuysen, A. A. Verberckmoes, L. Fu and R. A. Schoonheydt, J. Phys. Chem., 1996, 100, 9456–9461 CrossRef CAS.
  8. K. Arya, U. C. Rajesh and D. S. Rawat, Green Chem., 2012, 14, 3344–3351 RSC.
  9. M. Benaglia, A. Puglisi and F. Cozzi, Chem. Rev., 2003, 103, 3401–3429 CrossRef CAS PubMed.
  10. K. Cho, J. Yoo, H.-W. Noh, S. M. Lee, H. J. Kim, Y.-J. Ko, H.-Y. Jang and S. U. Son, J. Mater. Chem. A, 2017, 5, 8922–8926 RSC.
  11. S. Luo, J. Li, L. Zhang, H. Xu and J. P. Cheng, Chem. – Eur. J., 2008, 14, 1273–1281 CrossRef CAS PubMed.
  12. G. Wulff, Chem. Rev., 2002, 102, 1–28 CrossRef CAS PubMed.
  13. J. Schmidt, D. S. Kundu, S. Blechert and A. Thomas, Chem. Commun., 2014, 50, 3347–3349 RSC.
  14. J. Dong, Y. Liu and Y. Cui, Chem. Commun., 2014, 50, 14949–14952 RSC.
  15. Q. Sun, Z. Dai, X. Meng and F.-S. Xiao, Chem. Soc. Rev., 2015, 44, 6018–6034 RSC.
  16. D. Reinhard, W.-S. Zhang, Y. Vaynzof, F. Rominger, R. R. Schröder and M. Mastalerz, Chem. Mater., 2018, 30, 2781–2790 CrossRef CAS.
  17. P. Chen, J.-S. Sun, L. Zhang, W.-Y. Ma, F. Sun and G. Zhu, Sci. China Mater., 2018, 62, 194–202 CrossRef.
  18. W. J. Wang, M. Zhou and D. Q. Yuan, J. Mater. Chem. A, 2017, 5, 1334–1347 RSC.
  19. O. M. Yaghi, G. Li and H. Li, Nature, 1995, 378, 703–706 CrossRef CAS.
  20. A. P. Cote, A. I. Benin, N. W. Ockwig, M. O'Keeffe, A. J. Matzger and O. M. Yaghi, Science, 2005, 310, 1166–1170 CrossRef CAS PubMed.
  21. K. Liu, X. Zhang, X. Meng, W. Shi, P. Cheng and A. K. Powell, Chem. Soc. Rev., 2016, 45, 2423–2439 RSC.
  22. F. Ma, J. Xiong, Y.-S. Meng, J. Yang, H.-L. Sun and S. Gao, Inorg. Chem. Front., 2018, 5, 2875–2884 RSC.
  23. N. C. Burtch and K. S. Walton, Acc. Chem. Res., 2015, 48, 2850–2857 CrossRef CAS PubMed.
  24. Z. W. Wang, M. Chen, C. S. Liu, X. Wang, H. Zhao and M. Du, Chem. – Eur. J., 2015, 21, 17215–17219 CrossRef CAS PubMed.
  25. S. A. Diamantis, A. Margariti, A. D. Pournara, G. S. Papaefstathiou, M. J. Manos and T. Lazarides, Inorg. Chem. Front., 2018, 5, 1493–1511 RSC.
  26. Y. Cui, B. Li, H. He, W. Zhou, B. Chen and G. Qian, Acc. Chem. Res., 2016, 49, 483–493 CrossRef CAS PubMed.
  27. H. Liu, H. Li, F. Cheng, W. Shi, J. Chen and P. Cheng, Inorg. Chem., 2018, 57, 10640–10648 CrossRef CAS PubMed.
  28. R. Zhao, Z. Liang, S. Gao, C. Yang, B. Zhu, J. Zhao, C. Qu, R. Zou and Q. Xu, Angew. Chem., Int. Ed., 2019, 58, 1975–1979 CrossRef CAS PubMed.
  29. J. Lv, Y. X. Tan, J. Xie, R. Yang, M. Yu, S. Sun, M. D. Li, D. Yuan and Y. Wang, Angew. Chem., Int. Ed., 2018, 57, 12716–12720 CrossRef CAS PubMed.
  30. J. Lee, O. K. Farha, J. Roberts, K. A. Scheidt, S. T. Nguyen and J. T. Hupp, Chem. Soc. Rev., 2009, 38, 1450–1459 RSC.
  31. L. Ma, C. Abney and W. Lin, Chem. Soc. Rev., 2009, 38, 1248–1256 RSC.
  32. M. Yoon, R. Srirambalaji and K. Kim, Chem. Rev., 2012, 112, 1196–1231 CrossRef CAS PubMed.
  33. A. H. Chughtai, N. Ahmad, H. A. Younus, A. Laypkov and F. Verpoort, Chem. Soc. Rev., 2015, 44, 6804–6849 RSC.
  34. G. Kumar and S. K. Das, Inorg. Chem. Front., 2017, 4, 202–233 RSC.
  35. S. M. J. Rogge, A. Bavykina, J. Hajek, H. Garcia, A. I. Olivos-Suarez, A. Sepúlveda-Escribano, A. Vimont, G. Clet, P. Bazin, F. Kapteijn, M. Daturi, E. V. Ramos-Fernandez, F. X. Llabrés i Xamena, V. Van Speybroeck and J. Gascon, Chem. Soc. Rev., 2017, 46, 3134–3184 RSC.
  36. G. Yuan, H. Jiang, L. Zhang, Y. Liu and Y. Cui, Coord. Chem. Rev., 2019, 378, 483–499 CrossRef CAS.
  37. H. He, Y. Q. Xue, S. Q. Wang, Q. Q. Zhu, J. Chen, C. P. Li and M. Du, Inorg. Chem., 2018, 57, 15062–15068 CrossRef CAS PubMed.
  38. Y. X. Tan, X. Yang, B. B. Li and D. Yuan, Chem. Commun., 2016, 52, 13671–13674 RSC.
  39. L. Liang, C. Liu, F. Jiang, Q. Chen, L. Zhang, H. Xue, H. L. Jiang, J. Qian, D. Yuan and M. Hong, Nat. Commun., 2017, 8, 1233 CrossRef PubMed.
  40. J. Liu, L. Chen, H. Cui, J. Zhang, L. Zhang and C. Y. Su, Chem. Soc. Rev., 2014, 43, 6011–6061 RSC.
  41. L. Jiao, Y. Wang, H. L. Jiang and Q. Xu, Adv. Mater., 2018, 30, e1703663 CrossRef PubMed.
  42. J. S. Seo, D. Whang, H. Lee, S. I. Jun, J. Oh, Y. J. Jeon and K. Kim, Nature, 2000, 404, 982–986 CrossRef CAS PubMed.
  43. R. E. Morris and X. Bu, Nat. Chem., 2010, 2, 353–361 CrossRef CAS PubMed.
  44. T. Drake, P. Ji and W. Lin, Acc. Chem. Res., 2018, 51, 2129–2138 CrossRef CAS PubMed.
  45. Z. Wang and S. M. Cohen, Chem. Soc. Rev., 2009, 38, 1315–1329 RSC.
  46. J. D. Martell, L. B. Porter-Zasada, A. C. Forse, R. L. Siegelman, M. I. Gonzalez, J. Oktawiec, T. Runcevski, J. Xu, M. Srebro-Hooper, P. J. Milner, K. A. Colwell, J. Autschbach, J. A. Reimer and J. R. Long, J. Am. Chem. Soc., 2017, 139, 16000–16012 CrossRef CAS PubMed.
  47. Z. Wang and S. M. Cohen, J. Am. Chem. Soc., 2007, 129, 12368–12369 CrossRef CAS PubMed.
  48. S. M. Cohen, Chem. Rev., 2012, 112, 970–1000 CrossRef CAS PubMed.
  49. C. Tan, X. Han, Z. Li, Y. Liu and Y. Cui, J. Am. Chem. Soc., 2018, 140, 16229–16236 CrossRef CAS PubMed.
  50. Z. Han, W. Shi and P. Cheng, Chin. Chem. Lett., 2018, 29, 819–822 CrossRef CAS.
  51. R. Kitaura, G. Onoyama, H. Sakamoto, R. Matsuda, S. Noro and S. Kitagawa, Angew. Chem., Int. Ed., 2004, 43, 2684–2687 CrossRef CAS PubMed.
  52. B. Chen, X. Zhao, A. Putkham, K. Hong, E. B. Lobkovsky, E. J. Hurtado, A. J. Fletcher and K. M. Thomas, J. Am. Chem. Soc., 2008, 130, 6411–6423 CrossRef CAS PubMed.
  53. C. M. McGuirk, M. J. Katz, C. L. Stern, A. A. Sarjeant, J. T. Hupp, O. K. Farha and C. A. Mirkin, J. Am. Chem. Soc., 2015, 137, 919–925 CrossRef CAS PubMed.
  54. Z. F. Ju, S. C. Yan and D. Q. Yuan, Chem. Mater., 2016, 28, 2000–2010 CrossRef CAS.
  55. F. Song, C. Wang, J. M. Falkowski, L. Ma and W. Lin, J. Am. Chem. Soc., 2010, 132, 15390–15398 CrossRef CAS PubMed.
  56. S. H. Cho, B. Ma, S. T. Nguyen, J. T. Hupp and T. E. Albrecht-Schmitt, Chem. Commun., 2006, 2563–2565 RSC.
  57. S. C. Xiang, Z. Zhang, C. G. Zhao, K. Hong, X. Zhao, D. R. Ding, M. H. Xie, C. D. Wu, M. C. Das, R. Gill, K. M. Thomas and B. Chen, Nat. Commun., 2011, 2, 204 CrossRef PubMed.
  58. Y. Cui, H. L. Ngo, P. S. White and W. Lin, Chem. Commun., 2003, 994–995 RSC.
  59. C. D. Wu, A. Hu, L. Zhang and W. Lin, J. Am. Chem. Soc., 2005, 127, 8940–8941 CrossRef CAS PubMed.
  60. S. Regati, Y. He, M. Thimmaiah, P. Li, S. Xiang, B. Chen and J. C. Zhao, Chem. Commun., 2013, 49, 9836–9838 RSC.
  61. Z. Zhang, Y. R. Ji, L. Wojtas, W. Y. Gao, S. Ma, M. J. Zaworotko and J. C. Antilla, Chem. Commun., 2013, 49, 7693–7695 RSC.
  62. M. Zheng, Y. Liu, C. Wang, S. Liu and W. Lin, Chem. Sci., 2012, 3, 2623 RSC.
  63. W. Gong, X. Chen, H. Jiang, D. Chu, Y. Cui and Y. Liu, J. Am. Chem. Soc., 2019, 141, 7498–7508 CrossRef CAS PubMed.
  64. H. Y. An, E. B. Wang, D. R. Xiao, Y. G. Li, Z. M. Su and L. Xu, Angew. Chem., Int. Ed., 2006, 45, 904–908 CrossRef CAS PubMed.
  65. M. J. Ingleson, J. Bacsa and M. J. Rosseinsky, Chem. Commun., 2007, 3036–3038 RSC.
  66. Q. Ye, Y. M. Song, G. X. Wang, K. Chen, D. W. Fu, P. W. Chan, J. S. Zhu, S. D. Huang and R. G. Xiong, J. Am. Chem. Soc., 2006, 128, 6554–6555 CrossRef CAS PubMed.
  67. J. J. Qian, F. L. Jiang, D. Q. Yuan, X. J. Li, L. J. Zhang, K. Z. Su and M. C. Hong, J. Mater. Chem. A, 2013, 1, 9075–9082 RSC.
  68. J. Pang, F. Jiang, M. Wu, C. Liu, K. Su, W. Lu, D. Yuan and M. Hong, Nat. Commun., 2015, 6, 7575 CrossRef PubMed.
  69. B. Li, W. Wang, Z. Hong, E. M. El-Sayed and D. Yuan, Chem. Commun., 2019, 55, 6926–6929 RSC.
  70. S. S.-Y. Chui, S. M.-F. Lo, J. P. H. Charmant, A. G. Orpen and I. D. Williams, Science, 1999, 283, 1148–1150 CrossRef PubMed.
  71. Z. X. Xu, Y. X. Tan, H. R. Fu, J. Liu and J. Zhang, Inorg. Chem., 2014, 53, 12199–12204 CrossRef CAS PubMed.
  72. S.-Y. Zhang, C.-X. Yang, W. Shi, X.-P. Yan, P. Cheng, L. Wojtas and M. J. Zaworotko, Chem, 2017, 3, 281–289 CAS.
  73. Y. Liu, W. Xuan and Y. Cui, Adv. Mater., 2010, 22, 4112–4135 CrossRef CAS PubMed.
  74. Z. X. Xu, H. R. Fu, X. Wu, Y. Kang and J. Zhang, Chem. – Eur. J., 2015, 21, 10236–10240 CrossRef CAS PubMed.
  75. Z. X. Xu, Y. X. Tan, H. R. Fu, Y. Kang and J. Zhang, Chem. Commun., 2015, 51, 2565–2568 RSC.
  76. C. Zhuo, Y. Wen, S. Hu, T. Sheng, R. Fu, Z. Xue, H. Zhang, H. Li, J. Yuan, X. Chen and X. Wu, Inorg. Chem., 2017, 56, 6275–6280 CrossRef CAS PubMed.
  77. D. Alezi, A. M. Peedikakkal, L. J. Weselinski, V. Guillerm, Y. Belmabkhout, A. J. Cairns, Z. Chen, L. Wojtas and M. Eddaoudi, J. Am. Chem. Soc., 2015, 137, 5421–5430 CrossRef CAS PubMed.
  78. S. Yuan, T. F. Liu, D. Feng, J. Tian, K. Wang, J. Qin, Q. Zhang, Y. P. Chen, M. Bosch, L. Zou, S. J. Teat, S. J. Dalgarno and H. C. Zhou, Chem. Sci., 2015, 6, 3926–3930 RSC.
  79. G. Lan, K. Ni, S. S. Veroneau, X. Feng, G. T. Nash, T. Luo, Z. Xu and W. Lin, J. Am. Chem. Soc., 2019, 141, 4204–4208 CrossRef CAS PubMed.
  80. J. Castells-Gil, N. M. Padial, N. Almora-Barrios, J. Albero, A. R. Ruiz-Salvador, J. Gonzalez-Platas, H. Garcia and C. Marti-Gastaldo, Angew. Chem., Int. Ed., 2018, 57, 8453–8457 CrossRef CAS PubMed.
  81. M. H. Beyzavi, N. A. Vermeulen, A. J. Howarth, S. Tussupbayev, A. B. League, N. M. Schweitzer, J. R. Gallagher, A. E. Platero-Prats, N. Hafezi, A. A. Sarjeant, J. T. Miller, K. W. Chapman, J. F. Stoddart, C. J. Cramer, J. T. Hupp and O. K. Farha, J. Am. Chem. Soc., 2015, 137, 13624–13631 CrossRef CAS PubMed.
  82. L. Cao, Z. Lin, F. Peng, W. Wang, R. Huang, C. Wang, J. Yan, J. Liang, Z. Zhang, T. Zhang, L. Long, J. Sun and W. Lin, Angew. Chem., Int. Ed., 2016, 55, 4962–4966 CrossRef CAS PubMed.
  83. J. H. Cavka, S. Jakobsen, U. Olsbye, N. Guillou, C. Lamberti, S. Bordiga and K. P. Lillerud, J. Am. Chem. Soc., 2008, 130, 13850–13851 CrossRef PubMed.
  84. A. Schaate, P. Roy, A. Godt, J. Lippke, F. Waltz, M. Wiebcke and P. Behrens, Chem. – Eur. J., 2011, 17, 6643–6651 CrossRef CAS PubMed.
  85. R. J. Marshall, C. L. Hobday, C. F. Murphie, S. L. Griffin, C. A. Morrison, S. A. Moggach and R. S. Forgan, J. Mater. Chem. A, 2016, 4, 6955–6963 RSC.
  86. Z. Lin, A. M. Slawin and R. E. Morris, J. Am. Chem. Soc., 2007, 129, 4880–4881 CrossRef CAS PubMed.
  87. D. Dang, P. Wu, C. He, Z. Xie and C. Duan, J. Am. Chem. Soc., 2010, 132, 14321–14323 CrossRef CAS PubMed.
  88. S. Y. Zhang, D. Li, D. Guo, H. Zhang, W. Shi, P. Cheng, L. Wojtas and M. J. Zaworotko, J. Am. Chem. Soc., 2015, 137, 15406–15409 CrossRef CAS PubMed.
  89. D. Yuan, D. Zhao, D. J. Timmons and H.-C. Zhou, Chem. Sci., 2011, 2, 103–106 RSC.
  90. G. C. Shearer, S. Chavan, S. Bordiga, S. Svelle, U. Olsbye and K. P. Lillerud, Chem. Mater., 2016, 28, 3749–3761 CrossRef CAS.
  91. G. C. Shearer, J. G. Vitillo, S. Bordiga, S. Svelle, U. Olsbye and K. P. Lillerud, Chem. Mater., 2016, 28, 7190–7193 CrossRef CAS.
  92. B. Slater, Z. Wang, S. Jiang, M. R. Hill and B. P. Ladewig, J. Am. Chem. Soc., 2017, 139, 18322–18327 CrossRef CAS PubMed.
  93. J. Pang, S. Yuan, J. Qin, M. Wu, C. T. Lollar, J. Li, N. Huang, B. Li, P. Zhang and H. C. Zhou, J. Am. Chem. Soc., 2018, 140, 12328–12332 CrossRef CAS PubMed.
  94. H. Wang, X. Dong, J. Lin, S. J. Teat, S. Jensen, J. Cure, E. V. Alexandrov, Q. Xia, K. Tan, Q. Wang, D. H. Olson, D. M. Proserpio, Y. J. Chabal, T. Thonhauser, J. Sun, Y. Han and J. Li, Nat. Commun., 2018, 9, 1745 CrossRef PubMed.
  95. S. Yuan, W. Lu, Y. P. Chen, Q. Zhang, T. F. Liu, D. Feng, X. Wang, J. Qin and H. C. Zhou, J. Am. Chem. Soc., 2015, 137, 3177–3180 CrossRef CAS PubMed.
  96. S. Yuan, Y. P. Chen, J. S. Qin, W. Lu, L. Zou, Q. Zhang, X. Wang, X. Sun and H. C. Zhou, J. Am. Chem. Soc., 2016, 138, 8912–8919 CrossRef CAS PubMed.
  97. C. X. Chen, Z. Wei, J. J. Jiang, Y. Z. Fan, S. P. Zheng, C. C. Cao, Y. H. Li, D. Fenske and C. Y. Su, Angew. Chem., Int. Ed., 2016, 55, 9932–9936 CrossRef CAS PubMed.
  98. K. D. Nguyen, C. Kutzscher, F. Drache, I. Senkovska and S. Kaskel, Inorg. Chem., 2018, 57, 1483–1489 CrossRef CAS PubMed.
  99. X. Feng, H. S. Jena, K. Leus, G. Wang, J. Ouwehand and P. Van Der Voort, J. Catal., 2018, 365, 36–42 CrossRef CAS.
  100. Z.-X. Xu, Y. Liu and J. Zhang, Inorg. Chem. Commun., 2016, 67, 44–46 CrossRef CAS.
  101. G. Ferey, C. Mellot-Draznieks, C. Serre, F. Millange, J. Dutour, S. Surble and I. Margiolaki, Science, 2005, 309, 2040–2042 CrossRef CAS PubMed.
  102. M. Banerjee, S. Das, M. Yoon, H. J. Choi, M. H. Hyun, S. M. Park, G. Seo and K. Kim, J. Am. Chem. Soc., 2009, 131, 7524–7525 CrossRef CAS PubMed.
  103. J. Chen, X. Chen, Z. Zhang, Z. Bao, H. Xing, Q. Yang and Q. Ren, Mol. Catal., 2018, 445, 163–169 CrossRef CAS.
  104. W. Zhu, C. He, P. Wu, X. Wu and C. Duan, Dalton Trans., 2012, 41, 3072–3077 RSC.
  105. J. Canivet, S. Aguado, G. Bergeret and D. Farrusseng, Chem. Commun., 2011, 47, 11650–11652 RSC.
  106. J. Bonnefoy, A. Legrand, E. A. Quadrelli, J. Canivet and D. Farrusseng, J. Am. Chem. Soc., 2015, 137, 9409–9416 CrossRef CAS PubMed.
  107. D. J. Lun, G. I. Waterhouse and S. G. Telfer, J. Am. Chem. Soc., 2011, 133, 5806–5809 CrossRef CAS PubMed.
  108. H. Furukawa, K. E. Cordova, M. O'Keeffe and O. M. Yaghi, Science, 2013, 341, 1230444 CrossRef PubMed.
  109. C. Kutzscher, H. C. Hoffmann, S. Krause, U. Stoeck, I. Senkovska, E. Brunner and S. Kaskel, Inorg. Chem., 2015, 54, 1003–1009 CrossRef CAS PubMed.
  110. S. Nießing, C. Czekelius and C. Janiak, Catal. Commun., 2017, 95, 12–15 CrossRef.
  111. C. Kutzscher, G. Nickerl, I. Senkovska, V. Bon and S. Kaskel, Chem. Mater., 2016, 28, 2573–2580 CrossRef CAS.
  112. D. De, T. K. Pal and P. K. Bharadwaj, Inorg. Chem., 2016, 55, 6842–6844 CrossRef CAS PubMed.
  113. M. Sartor, T. Stein, F. Hoffmann and M. Fröba, Chem. Mater., 2016, 28, 519–528 CrossRef CAS.
  114. N. L. Rosi, J. Kim, M. Eddaoudi, B. Chen, M. O'Keeffe and O. M. Yaghi, J. Am. Chem. Soc., 2005, 127, 1504–1518 CrossRef CAS PubMed.
  115. H. Deng, S. Grunder, K. E. Cordova, C. Valente, H. Furukawa, M. Hmadeh, F. Gandara, A. C. Whalley, Z. Liu, S. Asahina, H. Kazumori, M. O'Keeffe, O. Terasaki, J. F. Stoddart and O. M. Yaghi, Science, 2012, 336, 1018–1023 CrossRef CAS PubMed.
  116. D. J. Xiao, J. Oktawiec, P. J. Milner and J. R. Long, J. Am. Chem. Soc., 2016, 138, 14371–14379 CrossRef CAS PubMed.
  117. A. M. Fracaroli, P. Siman, D. A. Nagib, M. Suzuki, H. Furukawa, F. D. Toste and O. M. Yaghi, J. Am. Chem. Soc., 2016, 138, 8352–8355 CrossRef CAS PubMed.
  118. H. Deng, C. J. Doonan, H. Furukawa, R. B. Ferreira, J. Towne, C. B. Knobler, B. Wang and O. M. Yaghi, Science, 2010, 327, 846–850 CrossRef CAS PubMed.
  119. H. Furukawa, N. Ko, Y. B. Go, N. Aratani, S. B. Choi, E. Choi, A. O. Yazaydin, R. Q. Snurr, M. O'Keeffe, J. Kim and O. M. Yaghi, Science, 2010, 329, 424–428 CrossRef CAS PubMed.
  120. K. Koh, A. G. Wong-Foy and A. J. Matzger, Angew. Chem., Int. Ed., 2008, 47, 677–680 CrossRef CAS PubMed.
  121. K. Koh, A. G. Wong-Foy and A. J. Matzger, J. Am. Chem. Soc., 2010, 132, 15005–15010 CrossRef CAS PubMed.
  122. C. X. Chen, Z. W. Wei, J. J. Jiang, S. P. Zheng, H. P. Wang, Q. F. Qiu, C. C. Cao, D. Fenske and C. Y. Su, J. Am. Chem. Soc., 2017, 139, 6034–6037 CrossRef CAS PubMed.
  123. L. Liu, K. Konstas, M. R. Hill and S. G. Telfer, J. Am. Chem. Soc., 2013, 135, 17731–17734 CrossRef CAS PubMed.
  124. L. Liu, T. Y. Zhou and S. G. Telfer, J. Am. Chem. Soc., 2017, 139, 13936–13943 CrossRef CAS PubMed.
  125. T. Y. Zhou, B. Auer, S. J. Lee and S. G. Telfer, J. Am. Chem. Soc., 2019, 141, 1577–1582 CrossRef CAS PubMed.
  126. F. Song, C. Wang and W. Lin, Chem. Commun., 2011, 47, 8256–8258 RSC.
  127. Q. Xia, Z. Li, C. Tan, Y. Liu, W. Gong and Y. Cui, J. Am. Chem. Soc., 2017, 139, 8259–8266 CrossRef CAS PubMed.
  128. P. Wu, C. He, J. Wang, X. Peng, X. Li, Y. An and C. Duan, J. Am. Chem. Soc., 2012, 134, 14991–14999 CrossRef CAS PubMed.
  129. Z. Xia, C. He, X. Wang and C. Duan, Nat. Commun., 2017, 8, 361 CrossRef PubMed.
  130. C. Zou, Z. Zhang, X. Xu, Q. Gong, J. Li and C. D. Wu, J. Am. Chem. Soc., 2012, 134, 87–90 CrossRef CAS PubMed.
  131. Q. Han, C. He, M. Zhao, B. Qi, J. Niu and C. Duan, J. Am. Chem. Soc., 2013, 135, 10186–10189 CrossRef CAS PubMed.
  132. Q. Han, B. Qi, W. Ren, C. He, J. Niu and C. Duan, Nat. Commun., 2015, 6, 10007 CrossRef PubMed.
  133. Q. Han, W. Li, S. Wang, J. He, W. Du and M. Li, ChemCatChem, 2017, 9, 1801–1807 CrossRef CAS.
  134. O. K. Farha, A. M. Shultz, A. A. Sarjeant, S. T. Nguyen and J. T. Hupp, J. Am. Chem. Soc., 2011, 133, 5652–5655 CrossRef CAS PubMed.
  135. D. Feng, Z. Y. Gu, J. R. Li, H. L. Jiang, Z. Wei and H. C. Zhou, Angew. Chem., Int. Ed., 2012, 51, 10307–10310 CrossRef CAS PubMed.
  136. X. L. Yang, M. H. Xie, C. Zou, Y. He, B. Chen, M. O'Keeffe and C. D. Wu, J. Am. Chem. Soc., 2012, 134, 10638–10645 CrossRef CAS PubMed.
  137. W. Y. Gao, L. Wojtas and S. Ma, Chem. Commun., 2014, 50, 5316–5318 RSC.
  138. W. L. He, M. Zhao and C. D. Wu, Angew. Chem., Int. Ed., 2019, 58, 168–172 CrossRef CAS PubMed.
  139. B. List, R. A. Lerner and C. F. Barbas III, J. Am. Chem. Soc., 2000, 122, 2395–2396 CrossRef CAS.
  140. Y. Liu, X. Xi, C. Ye, T. Gong, Z. Yang and Y. Cui, Angew. Chem., Int. Ed., 2014, 53, 13821–13825 CrossRef CAS PubMed.
  141. Y. Zhang, X. Feng, S. Yuan, J. Zhou and B. Wang, Inorg. Chem. Front., 2016, 3, 896–909 RSC.
  142. T. Kitao, Y. Zhang, S. Kitagawa, B. Wang and T. Uemura, Chem. Soc. Rev., 2017, 46, 3108–3133 RSC.
  143. B. Le Ouay, S. Kitagawa and T. Uemura, J. Am. Chem. Soc., 2017, 139, 7886–7892 CrossRef CAS PubMed.
  144. C. S. Liu, M. Chen, J. Y. Tian, L. Wang, M. Li, S. M. Fang, X. Wang, L. M. Zhou, Z. W. Wang and M. Du, Chem. – Eur. J., 2017, 23, 3885–3890 CrossRef CAS PubMed.
  145. L. Peng, S. Yang, S. Jawahery, S. M. Moosavi, A. J. Huckaba, M. Asgari, E. Oveisi, M. K. Nazeeruddin, B. Smit and W. L. Queen, J. Am. Chem. Soc., 2019, 141, 12397–12405 CrossRef CAS PubMed.
  146. X.-W. Dong, Y. Yang, J.-X. Che, J. Zuo, X.-H. Li, L. Gao, Y.-Z. Hu and X.-Y. Liu, Green Chem., 2018, 20, 4085–4093 RSC.
  147. X. Han, Q. Xia, J. Huang, Y. Liu, C. Tan and Y. Cui, J. Am. Chem. Soc., 2017, 139, 8693–8697 CrossRef CAS PubMed.
  148. H. Li, X. Feng, P. Shao, J. Chen, C. Li, S. Jayakumar and Q. Yang, J. Mater. Chem. A, 2019, 7, 5482–5492 RSC.
  149. L. H. Li, X. L. Feng, X. H. Cui, Y. X. Ma, S. Y. Ding and W. Wang, J. Am. Chem. Soc., 2017, 139, 6042–6045 CrossRef CAS PubMed.
  150. S. Yan, X. Guan, H. Li, D. Li, M. Xue, Y. Yan, V. Valtchev, S. Qiu and Q. Fang, J. Am. Chem. Soc., 2019, 141, 2920–2924 CrossRef CAS PubMed.
  151. X. Wu, X. Han, Q. Xu, Y. Liu, C. Yuan, S. Yang, Y. Liu, J. Jiang and Y. Cui, J. Am. Chem. Soc., 2019, 141, 7081–7089 CrossRef CAS PubMed.
  152. X. Wang, X. Han, J. Zhang, X. Wu, Y. Liu and Y. Cui, J. Am. Chem. Soc., 2016, 138, 12332–12335 CrossRef CAS PubMed.
  153. X. Han, J. Huang, C. Yuan, Y. Liu and Y. Cui, J. Am. Chem. Soc., 2018, 140, 892–895 CrossRef CAS PubMed.
  154. H. L. Qian, C. X. Yang and X. P. Yan, Nat. Commun., 2016, 7, 12104 CrossRef CAS PubMed.
  155. H. C. Ma, C. C. Zhao, G. J. Chen and Y. B. Dong, Nat. Commun., 2019, 10, 3368 CrossRef PubMed.
  156. H. Xu, X. Chen, J. Gao, J. Lin, M. Addicoat, S. Irle and D. Jiang, Chem. Commun., 2014, 50, 1292–1294 RSC.
  157. H. Xu, J. Gao and D. Jiang, Nat. Chem., 2015, 7, 905–912 CrossRef CAS PubMed.
  158. H. S. Xu, S. Y. Ding, W. K. An, H. Wu and W. Wang, J. Am. Chem. Soc., 2016, 138, 11489–11492 CrossRef CAS PubMed.
  159. J. Zhang, X. Han, X. Wu, Y. Liu and Y. Cui, J. Am. Chem. Soc., 2017, 139, 8277–8285 CrossRef CAS PubMed.
  160. J. Zhang, X. Han, X. Wu, Y. Liu and Y. Cui, ACS Sustainable Chem. Eng., 2019, 7, 5065–5071 CrossRef CAS.
  161. G. Liu, J. Sheng and Y. Zhao, Sci. China Mater., 2017, 60, 1015–1022 CrossRef CAS.
  162. S. Kandambeth, A. Mallick, B. Lukose, M. V. Mane, T. Heine and R. Banerjee, J. Am. Chem. Soc., 2012, 134, 19524–19527 CrossRef CAS PubMed.
  163. M. J. Ingleson, J. P. Barrio, J. Bacsa, C. Dickinson, H. Park and M. J. Rosseinsky, Chem. Commun., 2008, 1287–1289 RSC.
  164. S. Lee, E. A. Kapustin and O. M. Yaghi, Science, 2016, 353, 808–811 CrossRef CAS PubMed.
  165. Y. Inokuma, S. Yoshioka, J. Ariyoshi, T. Arai, Y. Hitora, K. Takada, S. Matsunaga, K. Rissanen and M. Fujita, Nature, 2013, 495, 461–466 CrossRef CAS PubMed.

This journal is © the Partner Organisations 2020
Click here to see how this site uses Cookies. View our privacy policy here.